CAR-T cell therapy in myeloma: hopes and hurdles

Bibliographic Details
Main Author: Jean Luc Harousseau
Format: Article
Language:English
Published: Wolters Kluwer Health 2023-04-01
Series:Blood Science
Online Access:http://journals.lww.com/10.1097/BS9.0000000000000148
_version_ 1797817590222946304
author Jean Luc Harousseau
author_facet Jean Luc Harousseau
author_sort Jean Luc Harousseau
collection DOAJ
first_indexed 2024-03-13T08:55:46Z
format Article
id doaj.art-ca6d9b28c73f404b9efb02b67c40e3f5
institution Directory Open Access Journal
issn 2543-6368
language English
last_indexed 2024-03-13T08:55:46Z
publishDate 2023-04-01
publisher Wolters Kluwer Health
record_format Article
series Blood Science
spelling doaj.art-ca6d9b28c73f404b9efb02b67c40e3f52023-05-29T03:32:21ZengWolters Kluwer HealthBlood Science2543-63682023-04-015213613710.1097/BS9.0000000000000148202304000-00010CAR-T cell therapy in myeloma: hopes and hurdlesJean Luc Harousseau0Institut de Cancérologie de l’Ouest, Saint Herblain, Francehttp://journals.lww.com/10.1097/BS9.0000000000000148
spellingShingle Jean Luc Harousseau
CAR-T cell therapy in myeloma: hopes and hurdles
Blood Science
title CAR-T cell therapy in myeloma: hopes and hurdles
title_full CAR-T cell therapy in myeloma: hopes and hurdles
title_fullStr CAR-T cell therapy in myeloma: hopes and hurdles
title_full_unstemmed CAR-T cell therapy in myeloma: hopes and hurdles
title_short CAR-T cell therapy in myeloma: hopes and hurdles
title_sort car t cell therapy in myeloma hopes and hurdles
url http://journals.lww.com/10.1097/BS9.0000000000000148
work_keys_str_mv AT jeanlucharousseau cartcelltherapyinmyelomahopesandhurdles